General Information of the Compound
| Compound ID |
CP0571295
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-6-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H29N7O3
|
||||||||||||||||||
| Molecular Weight |
535.608
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC[C@@H]1\C=C\C(=O)Nc1cc2c(Nc3ccc(Oc4ccc5nccn5c4)c(C)c3)ncnc2cc1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29N7O3/c1-19-14-20(5-8-27(19)40-22-7-9-28-31-11-13-37(28)17-22)34-30-23-15-25(26(38)16-24(23)32-18-33-30)35-29(39)10-6-21-4-3-12-36(21)2/h5-11,13-18,21,38H,3-4,12H2,1-2H3,(H,35,39)(H,32,33,34)/b10-6+/t21-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YSTSGFGNZVLCQE-VMLCMGRWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2